Acura Pharmaceuticals reported 613K in Sales Revenues for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acelrx Pharmaceuticals ACRX:US $ 0.44M 0.44M
Acura Pharmaceuticals ACUR:US 613K 31K
Intra Cellular Therapies ITCI:US $ 35M 9.32M
Johnson & Johnson JNJ:US $ 23426M 1378M
Nektar Therapeutics NKTR:US $ 24.82M 0.19M
Pfizer PFE:US $ 25661M 2026M
Rigel Pharmaceuticals RIGL:US $ 16.74M 3.67M
Shionogi 4507:JP Y 115512M 40972M
Sun Pharmaceuticals SUNP:IN IR 94467.6M 4163M
Teva Pharmaceutical TEVA:IT 3.66B 439M
Xeris Pharmaceuticals Inc XERS:US $ 22.07M 644K